Amorepacific's authentic derma brand, AESTURA, today announced its official entry into the Chinese market, spearheading its launch through the nation's premier e-commerce platforms.
In alignment with the strong preference for online shopping among Chinese consumers, AESTURA will execute a strategic and phased market entry, inaugurating official brand stores on major platforms including Tmall, Douyin, JD.com, and VIP.com.
The brand will introduce its entire ATOBARRIER365 line to the Chinese market, featuring the acclaimed ATOBARRIER365 Cream alongside its companion ampoule, lotion, and serum. The ATOBARRIER365 Cream, affectionately known as the 'capsule cream,' has solidified its status as AESTURA's leading steady seller, backed by a remarkable legacy of achievements including sales of one product every seven seconds, surpassing seven million units1 in cumulative sales, and securing the title of the No. 1 cream at Olive Young2, Korea's premier health and beauty retailer.
A representative for AESTURA articulated the brand's vision, stating, "Through this strategic, online-centric entry, we anticipate connecting with local Chinese consumers with sensitive skin in a more direct and convenient manner. As a leading derma brand representing Korea, AESTURA has established a robust market presence through extensive research and collaboration with dermatological experts, and we anticipate an equally enthusiastic reception in the Chinese market."
Forged from a forty-year heritage of dermatological research that began with Pacific Pharma in 1982, AESTURA continues its trajectory of consistent and remarkable growth. The brand's prestigious standing is undisputed, having been honored as the No. 1 hospital cosmetic brand for nine consecutive years3 and recognized as the No. 1 selling dermocosmetic facial care brand in Korea for 20244.
Following its successful entries into Asian markets, beginning with Japan and expanding to Vietnam and Thailand, AESTURA is now rapidly accelerating its expansion. This year marks a significant broadening of its global footprint into the United States, Canada, and Australia, amplifying its momentum as a quintessential K-Beauty derma brand on the world stage.
1 Based on cumulative sales volume from launch through May 2025 (includes pre-renewal version of the cream).
2 Based on the Cream category at the Olive Young Awards 2024.
3 Korean Consumer Brand Committee, Grand Prize in the Hospital Cosmetics category at the Brand of the Year Awards, 2016-2024.
4 Euromonitor International; Beauty and Personal Care 2025 edition, based on retail sales value in 2024.